Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling
Maiara Camotti Montanha, Francesc Fàbrega, Alice Howarth, Nicolas Cottura, Hannah Kinvig, Fazila Bunglawala, Andrew W. Lloyd, Paolo Denti, Catriona Waitt, Marco Siccardi
Topics & Concepts
Physiologically based pharmacokinetic modellingRitonavirAtazanavirPharmacologyPharmacokineticsMedicineDrugDosingRifampicinViral loadHuman immunodeficiency virus (HIV)TuberculosisAntiretroviral therapyVirologyPathologyHIV/AIDS drug development and treatmentPharmacological Effects and Toxicity StudiesDrug Transport and Resistance Mechanisms